Cancer Chemotherapy and Pharmacology (CCP)

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, chemotherapeutic or pharmacologic aspects of cellular therapy, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.

Cancer Chemotherapy and Pharmacology (CCP) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology (medical), Cancer Research, Pharmacology, Toxicology, Oncology, clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, indications for chemotherapy in cancer treatment strategy , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1432-0843, Established: 1978, Impact Factor: 2.3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE